Dermatológia pre prax 2/2011
Brief overview of surgical and pharmacological treatment of melanoma
Paper presents an overview of current surgical and pharmacological treatment and suggests its perspectives. Malignant melanoma accounts for only 4% of skin cancers; however, it is the cause of mortality in up to 79% of patients suffering from malignancies of the skin. Current treatment options for melanoma are limited. The only treatment option in the adjuvant therapy is interferon. Treatment of metastatic melanoma remains insufficient.
Keywords: malignant melanoma, surgical treatment, pharmacological treatment
